Federal Register / Vol. 88, No. 163 / Thursday, August 24, 2023 / Notices 57963 

meetings and will make every effort to 

accommodate persons with disabilities. 

If you require accommodations due to a 

disability, please contact LaToya Bonner 

(see FOR FURTHER INFORMATION CONTACT) 

at least 7 days in advance of the 

meeting. 

FDA is committed to the orderly 

conduct of its advisory committee 

meetings. Please visit our website at 

https://www.fda.gov/ 

AdvisoryCommittees/AboutAdvisory

Committees/ucm111462.htm for 

procedures on public conduct during 

advisory committee meetings. 

Notice of this meeting is given under 

the Federal Advisory Committee Act (5 

U.S.C. 1001 et seq.). This meeting notice 

also serves as notice that, pursuant to 21 

CFR 10.19, the requirements in 21 CFR 

14.22(b), (f), and (g) relating to the 

location of advisory committee meetings 

are hereby waived to allow for this 

meeting to take place using an online 

meeting platform. This waiver is in the 

interest of allowing greater transparency 

and opportunities for public 

participation, in addition to 

convenience for advisory committee 

members, speakers, and guest speakers. 

No participant will be prejudiced by 

this waiver and that the ends of justice 

will be served by allowing for this 

modification to FDA’s advisory 

committee meeting procedures. 

Dated: August 21, 2023. 

Lauren K. Roth, 

Associate Commissioner for Policy. 

[FR Doc. 2023–18250 Filed 8–23–23; 8:45 am] 

BILLING CODE 4164–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Meeting of the Presidential Advisory 

Council on HIV/AIDS 

AGENCY: Office of the Assistant 

Secretary for Health, Office of the 

Secretary, Department of Health and 

Human Services. 

ACTION: Notice of a hybrid meeting. 

SUMMARY: As stipulated by the Federal 

Advisory Committee Act, the U.S. 

Department of Health and Human 

Service is hereby giving notice that the 

Presidential Advisory Council on HIV/ 

AIDS (PACHA or the Council) will 

convene the 78th full council meeting 

on Wednesday, September 20, 2023. 

The meeting will convene in Charleston, 

West Virginia and it will also utilize 

virtual technologies. The meeting will 

be open to the public. Due to limited 

space, pre-registration is encouraged for 

members of the public who wish to 

attend the meeting in-person. Please 

email your name to PACHA@hhs.gov by 

close of business Wednesday, 

September 13, 2023 to pre-reigster. 

There will be a public comment session 

during the meeting; pre-registration is 

required to provide public comment. To 

pre-register to provide public comment, 

please send an email to PACHA@

hhs.gov and include your name, 

organization, and title by close of 

business Wednesday, September 13, 

2023. If you decide you would like to 

provide public comment but do not preregister, you may submit your written 

statement by emailing PACHA@hhs.gov 

by close of business September 27, 

2023. The meeting agenda will be 

posted on the PACHA page on HIV.gov 

at https://www.hiv.gov/federalresponse/pacha/about-pacha prior to 

the meeting. 

DATES: The meeting will be held on 

Wednesday, September 20, 2023 from 

approximately 9 a.m.–6 p.m. (ET). 

ADDRESSES: The meeting will be located 

at the University of Charleston, 2300 

MacCorkle Ave. SE, Charleston, WV 

25304. To attend the meeting virtually, 

please visit www.hhs.gov/live. 

FOR FURTHER INFORMATION CONTACT: Ms. 

Caroline Talev, MPA, Senior 

Management Analyst, at PACHA@

hhs.gov or Caroline.Talev@hhs.gov, or 

please call 202–795–7697. Additional 

information can be obtained by 

accessing the Council’s page on the 

HIV.gov site at www.hiv.gov/pacha. 

SUPPLEMENTARY INFORMATION: PACHA 

was established by Executive Order 

12963, dated June 14, 1995, as amended 

by Executive Order 13009, dated June 

14, 1996 and is currently operating 

under the authority given in Executive 

Order 14048, dated September 30, 2021. 

The Council was established to provide 

advice, information, and 

recommendations to the Secretary 

regarding programs and policies 

intended to promote effective HIV 

diagnosis, treatment, prevention, and 

quality care services. The functions of 

the Council are solely advisory in 

nature. 

The Council consists of not more than 

35 members. Council members are 

selected from prominent community 

leaders with particular expertise in, or 

knowledge of, matters concerning HIV 

and AIDS, public health, global health, 

population health, philanthropy, 

marketing or business, as well as other 

national leaders held in high esteem 

from other sectors of society. PACHA 

selections also include persons with 

lived HIV experience and racial/ethnic 

and sexual and gender minority persons 

disproportionately affected by HIV. 

Council members are appointed by the 

Secretary. 

Dated: August 3, 2023. 

Caroline Talev, 

Senior Management Analyst, Office of 

Infectious Disease and HIV/AIDS Policy 

(OIDP), Alternate Federal Officer, PACHA, 

Office of the Assistant Secretary for Health 

(OASH), U.S. Department of Health and 

Human Services (HHS). 

[FR Doc. 2023–18267 Filed 8–23–23; 8:45 am] 

BILLING CODE 4150–43–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Meeting of the Presidential Advisory 

Council on HIV/AIDS 

AGENCY: Office of the Assistant 

Secretary for Health, Office of the 

Secretary, Department of Health and 

Human Services. 

ACTION: Notice; Solicitation of 

nominations for appointment to 

Presidential Advisory Council on HIV/ 

AIDS (PACHA). 

SUMMARY: The Office of the Assistant 

Secretary for Health (OASH) is seeking 

nominations for membership on the 

Presidential Advisory Council on HIV/ 

AIDS (referred to as PACHA and/or the 

Council). The PACHA is a federal 

advisory committee within the U. S. 

Department of Health and Human 

Services (HHS). Management support 

for the activities of this Council is the 

responsibility of the OASH. The 

qualified individuals will be nominated 

to the Secretary of Health and Human 

Services for consideration for 

appointment as members of the PACHA. 

Members of the Council, including the 

Chair, are appointed by the Secretary. 

Members are invited to serve for 

overlapping terms of up to four-year; 

terms of more than two years are 

contingent upon the authorized 

continuation of the Council. The 

Council was established to provide 

advice, information, and 

recommendations to the Secretary 

regarding programs, policies, and 

research to promote effective treatment, 

prevention and cure of HIV and AIDS, 

including considering common comorbidities, as needed to promote 

effective HIV diagnosis, treatment, 

prevention, and quality care services. 

The functions of the Council are solely 

advisory in nature. 

DATES: Nominations for membership on 

the PACHA must be received no later 

than 8:00 p.m. (ET) Friday, January 5, 

2024. Packages received after this time 

will not be considered for the current 

membership cycle. 


lotter on DSK11XQN23PROD with NOTICES1
57964 Federal Register / Vol. 88, No. 163 / Thursday, August 24, 2023 / Notices 

ADDRESSES: All nominations should be 

emailed in one email to PACHA@

hhs.gov with the subject line ‘‘PACHA 

Application 2024.’’ 

FOR FURTHER INFORMATION CONTACT: Ms. 

Caroline Talev, Senior Management 

Analyst and Alternate Designated 

Federal Officer to PACHA; email 

Caroline.Talev@hhs.gov and include in 

the subject line ‘‘PACHA Application 

2024’’ or please call 202–795–7697. 

Additional information about PACHA 

can be obtained by accessing the 

Council’s website at About PACHA | 

HIV.gov. 

SUPPLEMENTARY INFORMATION: PACHA 

was established by Executive Order 

12963, dated June 14, 1995 as amended 

by Executive Order 13009, dated June 

14, 1996. Under a Presidential 

memorandum, dated July 13, 2000 and 

under Executive Order 13703, dated 

July 30, 2015, certain authorities were 

given to the PACHA for the 

implementation of the National HIV/ 

AIDS Strategy for the United States 

(Strategy or NHAS). The Council was 

continued by Executive Order 14048, 

dated September 30, 2021. The Council 

was established to provide advice, 

information, and recommendations to 

the Secretary regarding programs and 

policies intended to promote effective 

prevention of HIV disease and AIDS. 

The functions of the Council are solely 

advisory in nature. The Council consists 

of not more than 35 members. Council 

members are selected from prominent 

community leaders with particular 

expertise in, or knowledge of, matters 

concerning HIV and AIDS, public 

health, global health, population health, 

faith, philanthropy, marketing or 

business, as well as other national 

leaders held in high esteem from other 

sectors of society. PACHA selections 

will also include persons with lived HIV 

experience and racial/ethnic and sexual 

and gender minority persons 

disproportionately affected by HIV. 

Council members are appointed by the 

Secretary. Pursuant to advance written 

agreement, Council members shall 

receive no stipend for the advisory 

service they render as members of 

PACHA. However, as authorized by law 

and in accordance with Federal travel 

regulations, PACHA members may 

receive per diem and reimbursement for 

travel expenses incurred in relation to 

performing duties for the Council. 

This announcement is to solicit 

nominations of qualified candidates to 

fill current and upcoming vacancies on 

the PACHA. 

Nominations 

Nominations are being sought for 

individuals who have expertise and 

qualifications necessary to contribute to 

the accomplishments of PACHA’s 

objectives. Federal employees will not 

be considered for membership. The 

membership of the Committee will 

reflect diverse individuals. To ensure 

that the Commission membership is 

fairly balanced in terms of the points of 

view presented, consideration is also 

given to organizations representing the 

health interest of racial and ethnic 

minority groups. Appointments shall be 

made without discrimination on the 

basis of age, race, ethnicity, gender, 

sexual orientation, gender identity, HIV 

status, disability, and cultural, religious, 

or socioeconomic status. Nominees 

must be U.S. citizens, and cannot be 

full-time employees of the U.S. 

Government. Committee members are 

Special Government Employees (SGEs), 

requiring the filing of financial 

disclosure reports at the beginning and 

annually during their terms. Individuals 

who are selected for appointment will 

be required to provide detailed 

information regarding their financial 

interests. Note that the need for different 

expertise varies from year to year and a 

candidate who is not selected for an 

open position may be reconsidered for 

a subsequent open position. SGE 

nominees must be U.S. citizens, and 

cannot be full-time employees of the 

U.S. Government. Candidates should 

submit the following items to be 

considered of appointment: 

• Current curriculum vitae or resume, 

including complete contact information 

(telephone numbers, mailing address, 

email address). 

• A biographical sketch of the 

nominee (200 words or fewer). 

• A letter of interest or personal 

statement from the nominee stating how 

their expertise would inform the work 

of PACHA. 

• At least one letter of 

recommendation from person(s) not 

employed by the U.S. Department of 

Health and Human Services. 

Individuals can nominate themselves 

for consideration of appointment to the 

Council. All nominations must include 

the required information in one email 

sent to PACHA.hhs.gov with the subject 

line, ‘‘PACHA Application 2024.’’ 

Incomplete nomination applications 

will not be processed for consideration. 

The Department is legally required to 

ensure that the membership of HHS 

Federal advisory committees is fairly 

balanced in terms of points of view 

represented and the functions to be 

performed by the advisory committee. 

Appointment to the Council shall be 

made without discrimination on the 

basis of age, race, ethnicity, gender, 

sexual orientation, disability, and 

cultural, religious, or socioeconomic 

status. The Standards of Ethical 

Conduct for Employees of the Executive 

Branch are applicable to individuals 

who are appointed as members of the 

Council. 

Dated: August 21, 2023. 

Caroline Talev, 

Senior Management Analyst, Alternate 

Designated Federal Officer, PACHA, Office 

of Infectious Disease and HIV/AIDS Policy, 

Office of the Assistant Secretary for Health, 

U.S. Department of Health and Human 

Services. 

[FR Doc. 2023–18261 Filed 8–23–23; 8:45 am] 

BILLING CODE 4150–43–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Eye Institute; Notice of Closed 

Meeting 

Pursuant to section 1009 of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Eye Institute 

Special Emphasis Panel; K99 Training Grant 

Applications. 

Date: September 13, 2023. 

Time: 12:00 p.m. to 3:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Eye Institute, 6700B 

Rockledge Drive, Bethesda, MD 20892 

(Virtual Meeting). 

Contact Person: Ashley Fortress, Ph.D., 

Designated Federal Official, Division of 

Extramural Activities, National Eye Institute, 

National Institutes of Health, 6700 B 

Rockledge Dr., Bethesda, MD 20817 (301) 

451–2020, ashley.fortress@nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program No. 93.867, Vision Research, 

National Institutes of Health, HHS) 


lotter on DSK11XQN23PROD with NOTICES1